Status:

COMPLETED

Effects of Hydroxychloroquine on Oral Complaints of Sjögren Patients

Lead Sponsor:

Ege University

Conditions:

Sjögren's Syndrome

Xerostomia

Eligibility:

FEMALE

Brief Summary

Chronic inflammation that comprises the exocrine glands' function leads to xerophthalmia and xerostomia in Sjögren's syndrome. The oral consequences range widely and they are related to decreased sali...

Eligibility Criteria

Inclusion

  • Patients who were recently diagnosed with primary SS according to American-European criteria and who were scheduled for HCQ treatment in Ege University Faculty of Medicine, Department of Rheumatology

Exclusion

  • Sjögren patients consuming alcohol or tobacco

Key Trial Info

Start Date :

January 1 2005

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 1 2009

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT00873496

Start Date

January 1 2005

End Date

January 1 2009

Last Update

April 1 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ege University School of Dentistry

Izmir, Bornova, Turkey (Türkiye), 35100